BCG on Health Care’s cover photo
BCG on Health Care

BCG on Health Care

Business Consulting and Services

Boston, Massachusetts 20,842 followers

Innovation | Digital Disruption | M&A | Improved Value-Based Systems.

About us

BCG partners with clients across the health care industry in all regions to identify their highest-value opportunities, address their most critical challenges, and transform their enterprises. Our customized and collaborative approach ensures that our clients achieve sustainable competitive advantage, build more capable organizations, and secure lasting results. Connect with us to discuss ideas and unlock new opportunities! Biopharmaceuticals: https://on.bcg.com/biopharmaceuticals Medical Devices & Technology: https://on.bcg.com/medical_devices Payers, Provider & Services: https://on.bcg.com/payers_provider_services

Website
https://on.bcg.com/payers_provider_services
Industry
Business Consulting and Services
Company size
10,001+ employees
Headquarters
Boston, Massachusetts

Updates

  • BCG on Health Care reposted this

    The Medicare Advantage market is entering one of the most complex and competitive eras yet. After years of benefit-driven growth, plan designs have converged and the economics supporting benefit richness weakened. The next wave of differentiation will come from segmentation-driven growth strategy. Carriers that tailor offerings to the real needs of distinct consumer segments will be positioned to win. In this article, we break down how the market reached this point and what it will take to compete in 2027 and beyond. #MedicareAdvantage

  • Unmet demand in women’s health is vast and concentrated. Across 23 health concerns, women report just 54% satisfaction, compared with 65% for men. Nearly a third of this gap is concentrated in weight management; skin, hair, and nail health; and mental health—areas where products often overlook women’s real symptoms and preferences. Drawing on insights from nearly 4,000 US consumers, BCG’s new report uncovers three systemic factors behind these unmet needs: https://lnkd.in/e7jVxAJR #WomensHealth #ConsumerInsights

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Two-way collaboration is becoming essential to how health care organizations manage risk. As functional teams monitor and report key risks, R&C synthesizes and interprets those inputs to create a single, enterprise-wide view. This shared model brings risk thinking into day-to-day operations and, enabled by digital analytics and AI, provides earlier signals, clearer patterns, and greater foresight for decision makers. Learn more here: https://on.bcg.com/48KQk4K #Compliance #RiskManagement

  • BCG was proud to sponsor and join leaders across the health care innovation and investment community at this year's Jefferies Global Healthcare Conference. This event brought together a wide range of perspectives on the opportunities shaping the sector, from renewed deal activity and advances in GLP-1 and Alzheimer’s therapies to the growing role of AI-enabled solutions. As part of the program, we hosted the "AI at Work: Turning Innovation into Impact" workshop, featuring BCG's Margaret Ayers, Julius Neiser, Chris Meier, and Michael Zaiac from Daiichi Sankyo Europe GmbH. Across the discussion, three themes stood out in how leading organizations are advancing AI: • Moving from isolated tools to end-to-end workflow redesign that embeds AI into daily roles and decisions • Scaling fewer high-value use cases to drive adoption and measurable impact • Building the capabilities and governance required to sustain transformation With tools like AI agents that support real-time HCP engagements and EditAI that streamlines and standardizes medical writing, organizations are beginning to realize clearer gains in efficiency, accuracy, and decision-making. Thank you to everyone who attended, and we look forward to continuing the conversation on how AI can help shape the future of health care! #JefferiesHealthcare #BCGatJefferies2025

  • Tariff volatility has become yet another headwind for medtech companies, joining a growing list of global disruptions from supply chain constraints to shifting regulations. But uncertainty is here to stay, and how companies respond today will shape the competitiveness of the entire sector tomorrow. Earlier this month, I had the opportunity to contribute a piece to MedCity News on what I see as a major opportunity hidden within this challenge: the chance to build the supply chain of the future. In the article, I share three priorities that can help medtech leaders move from compliance to resilience: ✅ Expand tariff control towers into full supply chain command centers that monitor risks in real time. ✅ Use AI to improve transparency across multi-tier supplier networks and uncover hidden dependencies. ✅ Redesign networks with future shocks in mind by balancing nearshoring, diversification, and regional resilience. As I wrote, the companies that thrive will be those that treat today’s trade disruptions not as one-off challenges, but as catalysts to future-proof their operations. Grateful to the MedCity team for the opportunity to share these perspectives and to highlight how medtech can turn disruption into lasting advantage. Read my full article here: http://spr.ly/60457GSQ7 #MedTech #SupplyChainResilience #AI #HealthcareInnovation #BCG

  • Cancer remains a leading cause of death worldwide, even as breakthroughs like checkpoint inhibitors and CAR-T cells have revolutionized treatment paradigms. mRNA cancer vaccines offer a distinctive way to generate new T-cell responses and target a broader spectrum of tumor antigens, opening the door to more durable immunity. Combined with a strong safety profile, scalable production, and inherent fit with individualized neoantigen design, they are quickly becoming a leading candidate in the evolution of precision oncology. Read our latest perspective on whether mRNA cancer vaccines could represent the next breakthrough 👉: https://on.bcg.com/4pdDran #Oncology #Immunotherapy #mRNA #HealthCareInnovation

  • Medtech leaders are feeling the squeeze with softening demand, pricing pressures, and rising costs tightening margins. Many are responding with an isolated cost-cutting approach, but the real opportunity lies in a comprehensive, end-to-end approach. Cost programs that start with procurement lay the foundation for change, enabling cost savings of 7-12% while increasing gross margins by up to 3%. Learn more: https://lnkd.in/gJ_wHNgc #MedTech #CostTransformation #AI #Procurement Paari Rajendran, Vikram Aggarwal, Abhinav Verma

    • No alternative text description for this image
  • The UK’s world-class research and clinical expertise make it a global leader in discovery science, yet much of that potential remains untapped. BCG’s latest research shows that by 2030, the health care sector could add ~£78 billion to GDP, a 76% increase over current projections. Capturing that growth will require tackling four systemic challenges: 1️⃣ 𝗪𝗼𝗿𝗸𝗳𝗼𝗿𝗰𝗲: Limited capacity for innovation, declining career pathways, and gaps in digital and AI fluency 2️⃣ 𝗗𝗮𝘁𝗮: Fragmented systems and siloed infrastructure restrict insight and integration 3️⃣ 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀: Innovators struggle to connect with the NHS and scale proven pilots 4️⃣ 𝗣𝗼𝗹𝗶𝗰𝘆: Slow approvals and weak incentives constrain innovation The report outlines three priorities for action to tackle these barriers and encourage greater innovation in health care: https://lnkd.in/g7w6wvMP

  • Bringing a new therapy to market can take up to 15 years and cost billions. In this high-stakes environment, even incremental gains in speed can change patient outcomes. BCG partnered with a leading #pharma company to deploy a multi-agent #AI system that integrates scientific databases, regulatory systems, and content platforms to accelerate medical writing timelines from months to weeks. Read the full story here: https://lnkd.in/gzQ_Ztcb

  • Last month, we hosted our 2nd annual BCG Health Care Leadership Forum, convening leaders from payer, provider, services, and investor organizations to explore "𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘯𝘨 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘋𝘪𝘴𝘳𝘶𝘱𝘵𝘪𝘰𝘯: 𝘕𝘦𝘸 𝘏𝘦𝘢𝘭𝘵𝘩 𝘊𝘢𝘳𝘦 𝘉𝘶𝘴𝘪𝘯𝘦𝘴𝘴 𝘔𝘰𝘥𝘦𝘭𝘴 𝘢𝘯𝘥 𝘚𝘵𝘳𝘢𝘵𝘦𝘨𝘪𝘤 𝘚𝘩𝘪𝘧𝘵𝘴." From shifting market dynamics to the rise of generative AI, the discussions were bold, candid, and focused on action. Across sessions, a shared direction came into focus: • 𝗥𝗲-𝗮𝗿𝗰𝗵𝗶𝘁𝗲𝗰𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝘀𝘆𝘀𝘁𝗲𝗺. Leaders are looking beyond incremental efficiency to transform how care is financed, delivered, and experienced • 𝗔𝗜 𝗮𝘀 𝗮𝗻 𝗮𝗺𝗽𝗹𝗶𝗳𝗶𝗲𝗿 𝗼𝗳 𝗵𝘂𝗺𝗮𝗻 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹. The conversation has moved past automation to how AI can extend capacity, improve clinical precision, and restore empathy in the system • 𝗧𝗵𝗲 𝗲𝗰𝗼𝗻𝗼𝗺𝗶𝗰𝘀 𝗼𝗳 𝘃𝗮𝗹𝘂𝗲 𝗮𝗿𝗲 𝗯𝗲𝗶𝗻𝗴 𝗿𝗲𝘄𝗿𝗶𝘁𝘁𝗲𝗻. New partnerships are aligning incentives around outcomes, access, and affordability—creating a more sustainable foundation for growth • 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗮𝘀 𝗮 𝗰𝗮𝘁𝗮𝗹𝘆𝘀𝘁. No single player can solve the challenges ahead; success will depend on ecosystems of trust, data, and shared accountability • 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗶𝗻 𝗺𝗼𝘁𝗶𝗼𝗻. The future will belong to those who act decisively amid uncertainty—testing, learning, and scaling faster than the change around them A huge thank you to our incredible speakers and panelists for their insights in charting the direction of change, and to our BCG moderators Sanjay Saxena, Karthik Prasad, Martin Reeves, Joshua Kellar, Nate Holobinko, David Sadoff, Natasha Taylor, and Ashkan Afkhami for sharing your expertise. The work doesn't stop here—we look forward to continuing these important conversations! #BCGHCLF25 #BCGInsights

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +3

Affiliated pages

Similar pages